MUSCAT: Khoula Hospital recently began to implement the Vagus Nerve Stimulation (VNS) technology to treat drug-resistant epilepsy. This initiative constitutes part of the hospital's efforts to expand specialised therapeutic services for epilepsy patients.
The implementation of this technology caps off the hospital's ongoing efforts to develop its surgical epilepsy treatment programme and provides advanced treatment options for patients who do not respond adequately to conventional medications, thereby enhancing the localisation of specialised medical services within the Sultanate of Oman.
Dr Ahmed bin Sulaiman al Azri, Senior Consultant Neurosurgeon who heads the Neurosurgery Unit at Khoula Hospital, said that Khoula Hospital’s launch of the VNS technology sets a new milestone in the hospital’s epilepsy treatment programme. He noted that the implementation of this technology is the outcome of integration among the hospital’s neurosurgery, neurology and epilepsy teams.
Dr Ahmed pointed out that expanding these services helps minimise the need to refer such cases for treatment abroad and provides patients with advanced, specialised treatment options within the national healthcare system. He affirmed that the upcoming phase will see the introduction of specialised surgeries under the epilepsy treatment programme. - ONA
Oman Observer is now on the WhatsApp channel. Click here
